Risk evaluation of a conversational antidepressant selection decision aid using simulated patients

Source article: A Patient Simulation Framework for Risk Assessment of Conversational Health Care AI: Development and Evaluation Study

Background Conversational AI systems are increasingly being deployed in health care for clinical decision support, but their performance varies substantially across patient communication styles, health literacy levels, and behavioral patterns. Static benchmarks cannot capture multiturn dynamics through which this variation compounds, and no current evaluation framework implements structured AI risk management guidance for conversational health care AI. The result is a structural risk: AI systems may perform well…

A Patient Simulation Framework for Risk Assessment of Conversational Health Care AI: Development and Evaluation Study
Friendly cautions to the heads of families and others, very necessary to be observed in order to preserve health and long life : with ample directions to nurses who attend the sick, women in child-bed, &c. : third edition with additions by Johnson, Robert Wallace, 1719 or 1720- Humphreys, James, 1748-1810, printer Ware, John, 1795-1864, former owner. Public domain
Trace impact readingContested
P 71The P score combines the specificity and measured human impact of the grounded problem claim with the strength of this Trace’s cited sources.

Both sides are scored from claims and sources, not community votes.

G 72The G score combines the specificity and measured human impact of the grounded gain claim with the strength of this Trace’s cited sources.

In brief

Researchers built a patient simulator for testing conversational health AI, aligned with the NIST AI Risk Management Framework's Map and Measure functions. It combined medical profiles drawn from All of Us health records, linguistic profiles covering a health literacy gradient, and cooperative, distracted, or adversarial behavior. They generated 500 simulated conversations with an AI decision aid for antidepressant selection in major depressive disorder.

The findings matter because average performance can hide unequal results: the decision aid did worse for people with limited health literacy, who the authors say carry the greatest burden of psychiatric illness. Static benchmarks missed this. The framework was tested on only one task, so how well it transfers to other clinical decision aids is still unknown.

Main points

  1. The simulator expressed 8210 medical concepts with 96.6% accuracy, according to human and LLM-judge annotation.
  2. Human interannotator agreement was substantial (κ=0.73), and the LLM judge agreed with human annotators at κ=0.78.
  3. Behavioral profiles were distinguished almost perfectly (κ=0.93), while linguistic profiles reached κ=0.61, the lower end of substantial agreement.
  4. Rank-1 concept retrieval rose from 47.6% to 81.9% between limited and proficient health literacy, with antidepressant recommendation accuracy declining correspondingly.

The gain

A simulation framework aligned with the NIST AI RMF exposes performance risks in conversational clinical AI before deployment, with simulated patients expressing medical concepts at high fidelity.

The problem

The antidepressant decision aid degraded steadily as health literacy fell, retrieving the top concept correctly 47.6% of the time for limited literacy versus 81.9% for proficient literacy.

The rundown

The medical profiles were built from All of Us electronic health records using risk ratio gating. Linguistic profiles modeled a health literacy gradient and condition-specific communication, and behavioral profiles covered cooperative, distracted, and adversarial engagement.

Validation checked profile fidelity through human annotation and a large language model judge. The authors then measured downstream effects on the decision aid's concept retrieval and its antidepressant recommendations across the 500 conversations.

The authors frame health literacy as a structural risk factor with direct equity implications. They argue that this kind of pre-deployment simulation can guide targeted risk mitigation, which static benchmarks cannot do.

What this doesn’t fix

The framework was evaluated only on antidepressant selection, so its usefulness for other clinical decision-aid tasks has not been shown.

Sources

  1. Peer-reviewedJMIR AI2026-10-05

The debate